XOMA Corporation XOMAO
Jul 14, 2026, 9:30 AM EDT
- YTD
- -2.04%
- 1 year
- -1.54%
- Market cap
- 301.58M
- Revenue (ttm)
- 21.61M
- Profit margin
- -138.67%
- EPS (ttm)
- 1.00
- P/E ratio
- 25.53
- Dividend
- 2.09 (8.14%)
- Ex-dividend date
- Oct 2, 2024
- YTD return
- -2.04%
- 1-year return
- -1.54%
- Avg volume
- 4.68K
- Open
- 25.00
- Previous close
- 25.00
- Day's range
- 25.00 – 25.00
- 52-week range
- 23.50 – 25.87
- Beta
- 0.90
Key statistics
- Enterprise value
- 279.27M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 3.55
- Dividend yield
- 8.14%
- Payout ratio
- 0.00%
- Revenue growth
- 767.10%
- Free cash flow
- -19.24M
- Total cash
- 142.84M
- Total debt
- 118.94M
- Return on equity
- -31.41%
- Short % of float
- 0.00%
- 50-day average
- 25.51
- 200-day average
- 25.29
Next earnings
Consensus EPS estimate 0.00.
About XOMA Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- xoma.com
News
Your note
Sign in to keep a note on XOMAO — it syncs with the Stock Master app.